Burden of Disease Matters When It Comes to Systemic Therapy for Prostate Cancer

被引:2
|
作者
Harrison, Michael R. [1 ]
Armstrong, Andrew J. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Duke Canc Inst, Dept Med, Durham, NC USA
[2] Duke Univ, Med Ctr, Duke Canc Inst, Dept Surg, Durham, NC USA
关键词
PROGNOSTIC MODEL; SURVIVAL; CASTRATION; MEN; CHEMOTHERAPY; NOMOGRAM;
D O I
10.1016/j.eururo.2014.02.032
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:448 / 450
页数:3
相关论文
共 50 条
  • [41] Systemic therapy in metastatic hormone-sensitive prostate cancer
    McDonald, Jodie
    O'Brien, Jonathan
    Kostos, Louise
    Lawrentschuk, Nathan
    Azad, Arun A.
    Murphy, Declan
    Chen, Kenneth
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 234 - 239
  • [42] Castration-resistant prostate cancer: systemic therapy in 2012
    Maluf, Fernando C.
    Smaletz, Oren
    Herchenhorn, Daniel
    CLINICS, 2012, 67 (04) : 389 - 394
  • [43] Prostate cancer and erectile dysfunction. Which therapy when?
    Sperling, H
    Noldus, J
    UROLOGE A, 2003, 42 (10): : 1351 - +
  • [44] Adverse effects of systemic cancer therapy on skeletal muscle: myotoxicity comes out of the closet
    Klassen, Pamela
    Schiessel, Dalton L.
    Baracos, Vickie E.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2023, 26 (03): : 210 - 218
  • [45] When Tissue Is No Longer the Issue: Tissue-Agnostic Cancer Therapy Comes of Age
    Luoh, Shiuh-Wen
    Flaherty, Keith T.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (04) : 233 - +
  • [46] The burden of radiation therapy to the bone in patients with prostate cancer and bone metastases
    Hess, Gregory P.
    Barlev, Arie
    Hill, Jerrold W.
    Fonseca, Eileen
    Chung, Karen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] When the Oxygen Level Matters Mostly During Radiation Therapy of Cervical Cancer?
    Wang, J.
    Mayr, N.
    Zhang, D.
    Grecula, J.
    Zhang, H.
    Li, K.
    Gupta, N.
    Yuh, W.
    MEDICAL PHYSICS, 2008, 35 (06) : 2987 - +
  • [48] Significant reduction in burden of metastatic disease by intermittent docetaxel therapy in a patient with castration-resistant prostate cancer
    Kirisawa, Takahiro
    Nakamura, Eijiro
    Okuno, Tomoya
    Hagimoto, Hiroki
    Matsuda, Ayumu
    Shinoda, Yasuo
    Komiyama, Motokiyo
    Fujimoto, Hiroyuki
    Matsui, Yoshiyuki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (02) : 98 - 102
  • [49] Significant reduction in burden of metastatic disease by intermittent docetaxel therapy in a patient with castration-resistant prostate cancer
    Takahiro Kirisawa
    Eijiro Nakamura
    Tomoya Okuno
    Hiroki Hagimoto
    Ayumu Matsuda
    Yasuo Shinoda
    Motokiyo Komiyama
    Hiroyuki Fujimoto
    Yoshiyuki Matsui
    International Cancer Conference Journal, 2024, 13 : 98 - 102
  • [50] For radiation therapy before surgery in esophageal cancer, dose matters, and with each answer comes more questions
    Hennon, Mark
    Yendamuri, Sai
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5662 - 5663